M. T. Goodman

M. T. Goodman is a Professor in the Department of Gynecologic Oncology at Heidelberg University's Faculty of Medicine, with extensive contributions to ovarian cancer research through major international consortia including the Ovarian Cancer Association Consortium (OCAC) and Ovarian Tumor Tissue Analysis (OTTA) consortium. With 77 publications documented in the DKFZ database from 2022-2025, Dr. Goodman's research focuses on the genetic and molecular underpinnings of ovarian cancer susceptibility and progression.

Dr. Goodman's research interests center on ovarian cancer genetics, with particular emphasis on identifying genetic risk variants, understanding tumor microenvironment dynamics, and developing risk stratification models. Their work spans molecular oncology, cancer epidemiology, and translational research, with significant contributions to understanding how genetic factors, hormone receptor expression, and immune responses influence ovarian cancer development and patient outcomes. Recent studies have explored pleiotropic risk alleles at the 19p13.1 locus, immunological features of long-term survivors, and the interplay between RB1 loss and BRCA deficiency in predicting treatment response.

The publication record demonstrates consistent involvement in large-scale, multinational studies analyzing genetic risk factors, tumor characteristics, and survival outcomes in ovarian cancer. These studies frequently employ sophisticated statistical frameworks for assessing interactions in risk stratification models and integrate multi-omics approaches to identify functional mechanisms underlying cancer susceptibility.

Dr. Goodman's research has been published in high-impact journals including Nature Communications, Journal of the National Cancer Institute, Clinical Cancer Research, and Gynecologic Oncology, reflecting significant contributions to the field of gynecologic oncology and cancer genetics.